Blood

Components and Functions of Blood

  • Cardiovascular System Components:

    • A Pump: The Heart.

    • Conducting Hoses: A series of blood vessels.

    • Fluid Connective Tissue: Blood.

  • Definition of Blood:

    • Specialized connective tissue consisting of cells suspended in a fluid matrix.

    • Whole Blood: The combination of plasma and formed elements.

  • Primary Functions of Blood:

    • Transportation: Dissolved gases, nutrients, hormones, and metabolic wastes.

    • Regulation: pH and ion composition of interstitial fluids throughout the body.

    • Restriction of Fluid Loss: Occurs at injury sites (hemostasis).

    • Defense: Against toxins and pathogens.

    • Stabilization: Maintenance of body temperature.

  • Whole Blood Composition:

    • Fractionation: The process of separating whole blood into plasma and formed elements.

    • Plasma: The fluid matrix, making up approximately 46−63%46-63\% (average 55%55\%) of blood volume.

    • Formed Elements: Cells and cell fragments, accounting for 37−54%37-54\% (average 45%45\%) of blood volume.

  • Physical Characteristics and Volumes:

    • Total Volume in Adult Males: 5−65-6 liters (5.3−6.45.3-6.4 quarts).

    • Total Volume in Adult Females: 4−54-5 liters (4.2−5.34.2-5.3 quarts).

    • Hematocrit: The percentage of formed elements in a blood sample (also called packed cell volume, or PCV).

      • Normal male hematocrit: 4646.

      • Normal female hematocrit: 4242.

      • The difference is due to androgens stimulating RBC production and estrogens not doing so.

Plasma: The Fluid Matrix of Blood

  • Plasma Composition:

    • Water (92%92\%): The primary solvent.

    • Plasma Proteins (7%7\%):

      • Albumins (60%60\%): Major contributors to plasma osmolarity; transport fatty acids, thyroid hormones, and some steroid hormones.

      • Globulins (35%35\%): Include antibodies (immunoglobulins) and transport globulins (hormone-binding proteins, metalloproteins, apolipoproteins, and steroid-binding proteins).

      • Fibrinogen (4%4\%): A soluble protein converted to insoluble fibrin during clotting. Once fibrinogen is removed from a sample, the remaining fluid is called serum.

      • Other Plasma Proteins (1%1\%): Specialized enzymes and hormones.

    • Other Solutes (1%1\%): Nutrients, electrolytes, and organic wastes.

  • Plasma vs. Interstitial Fluid:

    • Similarities exist because of continuous exchange of water, ions, and small solutes across capillary walls.

    • Differences include levels of respiratory gases (O2O_2 and CO2CO_2) and the higher concentration of dissolved proteins in plasma, which cannot cross capillary walls.

Red Blood Cells (Erythrocytes)

  • Characteristics:

    • Make up 99.9%99.9\% of formed elements.

    • Hemoglobin (Hb): Red pigment that binds and transports oxygen and carbon dioxide.

    • Anucleate: Mature RBCs lack nuclei, mitochondria, and ribosomes.

    • Lifespan: Approximately 120120 days; they cannot divide, synthesize proteins, or repair themselves.

  • RBC Structure and Dimensions:

    • Shape: Biconcave discs with a thin central region and thicker outer margin.

    • Diameter: 7.2−8.4 μm7.2-8.4\,\mu m.

    • Edge Thickness: 2.31−2.85 μm2.31-2.85\,\mu m.

    • Central Thickness: 0.45−1.16 μm0.45-1.16\,\mu m.

  • Functional Effects of Structure:

    • High Surface-Area-to-Volume Ratio: Facilitates quick absorption and release of oxygen.

    • Rouleaux Formation: RBCs can form stacks to flow smoothly through narrow vessels.

    • Flexibility: A 7.8 μm7.8\,\mu m RBC can bend to pass through a 4 μm4\,\mu m capillary.

  • Hemoglobin (Hb) Structure and Function:

    • Complex quaternary structure consisting of four globular protein subunits: two alpha (α\alpha) chains and two beta (β\beta) chains.

    • Heme: Each subunit contains one heme molecule held by a protein chain.

    • Iron Ion: Each heme contains one iron ion that interacts with oxygen.

    • Oxygen Binding: Forms oxyhemoglobin (HbO2HbO_2) (bright red). Dissociation forms deoxyhemoglobin (dark red).

    • Quantities: Each RBC contains about 280280 million Hb molecules, allowing one RBC to carry over 11 billion O2O_2 molecules.

    • Fetal Hemoglobin: Found in embryos/fetuses; binds oxygen more strongly than adult Hb to take up oxygen from maternal blood.

    • Gas Transport: In peripheral capillaries (low O2O_2), Hb releases O2O_2 and binds CO2CO_2 to form carbaminohemoglobin. In the lungs (high O2O_2), Hb binds O2O_2 and releases CO2CO_2.

  • RBC Turnover and Erythropoiesis:

    • Turnover: 1%1\% of circulating RBCs are replaced daily; approximately 33 million new RBCs enter the bloodstream per second.

    • Hemopoiesis/Hematopoiesis: Production of formed elements from myeloid and lymphoid stem cells.

    • Erythropoiesis: Specifically the formation of RBCs. In adults, this occurs only in myeloid tissue (red bone marrow).

    • Hemocytoblasts: Hematopoietic stem cells (HSCs) that produce myeloid stem cells (RBCs, some WBCs) and lymphoid stem cells (lymphocytes).

    • Differentiation Stages: Hemocytoblast →\rightarrow Myeloid Stem Cell →\rightarrow Proerythroblast →\rightarrow Erythroblast stages (nucleus is ejected) →\rightarrow Reticulocyte →\rightarrow Mature Erythrocyte.

    • Regulation: Controlled by Erythropoietin (EPO), a hormone released by kidneys and liver during hypoxia (low tissue oxygen).

    • Nutritional Requirements: Amino acids, iron, folic acid, vitamin B12B_{12}, and vitamin B6B_6.

  • Hemoglobin Recycling:

    • Macrophages in the spleen, liver, and red bone marrow engulf old RBCs and break down Hb.

    • Iron: Removed from heme and transported by transferrin back to red bone marrow or stored in the liver.

    • Heme conversion: Heme →\rightarrow Biliverdin (green) →\rightarrow Bilirubin (orange-yellow).

    • Excretion: Bilirubin is released into the blood (bound to albumin), absorbed by the liver, and excreted in bile. In the large intestine, it is converted to urobilins and stercobilins.

    • Disorders:

      • Hemoglobinuria: Red/brown urine due to high hemolysis in the bloodstream.

      • Hematuria: Intact RBCs in urine, indicating kidney/vessel damage.

      • Jaundice: Buildup of bilirubin caused by liver blockage or inability to process it.

  • Anemia:

    • Occurs when hematocrit or Hb content is reduced, interfering with oxygen delivery.

    • Iron-deficiency anemia: Lack of iron prevents Hb synthesis.

    • Aplastic anemia: Bone marrow failure.

    • Pernicious anemia: Deficiency of vitamin B12B_{12}.

    • Sickle cell anemia: Genetic disorder causing abnormal Hb shape.

Blood Types and Cross-Reactions

  • Surface Antigens: Substances (agglutinogens) on plasma membranes that identify cells as "self" to the immune system.

  • ABO Blood Group: Based on A and B antigens.

    • Type A: Surface antigen A; Plasma contains anti-B antibodies.

    • Type B: Surface antigen B; Plasma contains anti-A antibodies.

    • Type AB: Surface antigens A and B; Plasma contains no anti-A or anti-B antibodies.

    • Type O: No surface antigens; Plasma contains both anti-A and anti-B antibodies.

  • Rh Blood Group: Based on the Rh (D) antigen.

    • Rh Positive (Rh+Rh^+): Rh antigen present.

    • Rh Negative (Rh−Rh^-): Rh antigen absent.

  • Agglutinins (Antibodies): Plasma proteins that attack foreign RBC antigens, causing agglutination (clumping) and hemolysis.

  • Cross-Reaction: Also called a transfusion reaction. Occurs if donor and recipient types are incompatible.

  • Hemolytic Disease of the Newborn (HDN):

    • Condition: Also known as erythroblastosis fetalis. Typically occurs during a second pregnancy with an Rh+Rh^+ fetus and an Rh−Rh^- mother.

    • Sensitization: During the first delivery, mixing of fetal Rh+Rh^+ and maternal Rh−Rh^- blood stimulates the mother to produce anti-Rh antibodies.

    • Second Pregnancy: Maternal anti-Rh antibodies cross the placenta and destroy fetal RBCs.

    • Treatment: RhoGAM (anti-Rh antibodies) administered at weeks 26−2826-28 and during/after delivery prevents maternal sensitization.

White Blood Cells (Leukocytes)

  • General Characteristics:

    • Have nuclei and organelles; lack hemoglobin.

    • Functions: Defend against pathogens, remove toxins/wastes, attack abnormal cells.

    • Circulation: Can migrate out of blood vessels (diapedesis/emigration), use amoeboid movement, and exhibit positive chemotaxis toward chemical stimuli.

  • Types of WBCs:

    1. Neutrophils (50−70%50-70\%): Highly active phagocytes that attack bacteria; release prostaglandins and leukotrienes.

    2. Eosinophils (2−4%2-4\%): Engulf bacteria/protozoa; attack large parasites; sensitive to allergens.

    3. Basophils (<1%<1\%): Accumulate in damaged tissue; release histamine (vasodilator) and heparin (anticoagulant).

    4. Monocytes (2−8%2-8\%): Enter tissues to become macrophages; aggressive phagocytes; attract other phagocytes.

    5. Lymphocytes (20−40%20-40\%): Mostly in lymphatic system; provide specific immunity.

      • T cells: Cell-mediated immunity; attack foreign cells directly.

      • B cells: Humoral immunity; differentiate into plasma cells to produce antibodies.

      • Natural Killer (NK) cells: Detect and destroy abnormal (e.g., cancer) cells.

  • WBC Production (Leukopoiesis):

    • Regulated by Colony-Stimulating Factors (CSFs).

      • Multi-CSF: Increases production of all formed elements except lymphocytes.

      • GM-CSF: Stimulates granulocytes and monocytes.

      • G-CSF: Stimulates granulocytes.

      • M-CSF: Stimulates monocytes.

    • Lymphocytopoiesis: Production of lymphocytes in red bone marrow and peripheral lymphatic tissues (thymus, spleen, lymph nodes).

  • WBC Disorders:

    • Leukopenia: Low WBC count.

    • Leukocytosis: High WBC count (often indicates infection).

    • Leukemia: Cancer leading to extreme, abnormal leukocytosis.

Platelets (Thrombocytes)

  • Properties:

    • Cell fragments of megakaryocytes.

    • Count: 150,000−500,000150,000-500,000 per microliter (μL\mu L).

    • Lifespan: 9−129-12 days; removed by the spleen.

    • Functions: Release clotting chemicals, patch vessel walls, and contract to reduce the size of breaks.

  • Thrombocytopoiesis: Occurs in red bone marrow; megakaryocytes shed cytoplasm packets to form platelets.

Hemostasis (Cessation of Bleeding)

  • 1. Vascular Phase:

    • Lasts about 3030 minutes.

    • Triggered by local contraction of smooth muscle (vascular spasm).

    • Endothelial cells contract, expose the basement membrane, and release factors: ADP, tissue factor, endothelins (stimulate contraction/repair), and prostacyclin (inhibits activation outside the injury).

  • 2. Platelet Phase:

    • Begins within 1515 seconds.

    • Platelet Adhesion: Attachment to sticky endothelium and basement membrane.

    • Platelet Aggregation: Platelets stick to each other forming a platelet plug.

    • Release of Compounds: ADP, Thromboxane A2A_2, Serotonin, Clotting factors, Calcium ions (Ca2+Ca^{2+}), and PDGF (vessel repair).

  • 3. Coagulation Phase:

    • Starts 3030 seconds or more after injury.

    • Clotting Factors (Procoagulants): Include Ca2+Ca^{2+} and 1111 different proteins (proenzymes).

    • Pathways:

      • Extrinsic Pathway: Triggered by external tissue damage; releases Factor III (Tissue Factor); fast.

      • Intrinsic Pathway: Triggered by internal factors (e.g., damaged endothelium/collagen); uses Factor XII; slower.

      • Common Pathway: Where both pathways converge. Activated Factor X forms prothrombin activator, which converts prothrombin to thrombin. Thrombin then converts soluble fibrinogen to insoluble fibrin.

    • Feedback Control: Thrombin stimulates more tissue factor and platelet factor (PF−3PF-3), creating a positive feedback loop.

  • Essential Factors for Clotting:

    • Calcium Ions (Ca2+Ca^{2+}): Required by all three pathways.

    • Vitamin K: Required by the liver to synthesize four of the clotting factors.

  • Clotting Control and Dissolution:

    • Anticoagulants: Enzymes like Antithrombin-III, Heparin (from basophils), Thrombomodulin, and Prostacyclin.

    • Clot Retraction: Platelets contract, pulling vessel edges together over 30−6030-60 minutes.

    • Fibrinolysis: The gradual dissolving of the clot. Thrombin and tissue plasminogen activator (t-PA) activate plasminogen, producing plasmin, which digests the fibrin mesh.

  • Coagulation Disorders:

    • Thrombocytopenia: Low platelet count.

    • Hemophilia: Genetic lack of clotting factors.

    • Thrombophilia: Tendency to form blood clots (thrombi).

    • Deep Vein Thrombosis (DVT): Clot formation in deep veins.